Encompass Health Corporation growth

Reported trailing growth, forward expectations and three-year compound growth rates.

Trailing growth

Year over year

Revenue: +10.0%
EBITDA: +16.8%
EBIT: +17.7%
EPS: +23.8%
Free cash flow: +20.2%
Operating cash flow: +14.0%

Forward estimates

Revenue: +10.2%
EBITDA: -0.8%
EPS: +1.5%

Three-year CAGR

Revenue: +10.9%
EBITDA: +17.3%
EBIT: +18.7%
Net income: +27.8%
EPS: +27.4%
Free cash flow: +53.4%

Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.